跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
查看斯高帕斯 (Scopus) 概要
吳 貞宜
教授
醫學系皮膚學科
h-index
h10-index
h5-index
1842
引文
25
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
802
引文
17
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
264
引文
10
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2010
2026
每年研究成果
概覽
指紋
網路
研究成果
(93)
類似的個人檔案
(6)
指紋
查看啟用 Chen-Yi Wu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
National Cohort Study
80%
Taiwan
80%
95% Confidence Interval
63%
Hazard Ratio
61%
Population-based Cohort Study
61%
Psoriasis
39%
Bullous Pemphigoid
37%
Atopic Dermatitis
27%
Herpes Zoster
25%
Retrospective Cohort Study
21%
Risk Factors
21%
Cardiovascular Mortality
19%
Rosaceae
18%
Odds Ratio
14%
All-cause Mortality
14%
Air Quality Index
13%
TriNetX
12%
Hypertension
11%
Mortality Risk
11%
Postherpetic Neuralgia
11%
Comorbidity
10%
Type 2 Diabetic Patients
10%
Incidence Rate
10%
Population-based Study
10%
Mortality in Elderly
10%
Vitiligo
9%
Body Mass Index
9%
Taiwan National Health Insurance Research Database
9%
Older Adults
9%
Hepatocellular Carcinoma
9%
Community-dwelling Older Adults
9%
Cigarette Smoking
9%
Obesity
9%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
9%
Nucleos(t)ide Analogues
9%
Gemcitabine
9%
Collaborative Coefficient
9%
Team Effectiveness
9%
Interprofessional Teams
9%
Interprofessional Collaboration
9%
Nested Case-control Study
9%
Proprotein Convertase Subtilisin/kexin Type 9 Inhibitors
9%
Non-melanoma Skin Cancer
9%
COVID-19
9%
Hepatocellular Carcinoma Patient
9%
National Health Insurance Research Database (NHIRD)
9%
Dementia
8%
Decreased Risk
8%
Adjusted Hazard Ratio
7%
Taipei
7%
Medicine and Dentistry
Cohort Analysis
100%
Hazard Ratio
40%
Bullous Pemphigoid
37%
Atopic Dermatitis
19%
Psoriasis
19%
Rhinophyma
18%
Disseminated Herpes Zoster
18%
Retrospective Cohort Study
16%
Malignant Neoplasm
13%
Infection
11%
Cardiovascular System
10%
Case-Control Study
9%
Proportional Hazards Model
9%
Odds Ratio
9%
Cardiovascular Mortality
9%
Cigarette Smoking
9%
Non Melanoma Skin Cancer
9%
Proprotein Convertase 9
9%
Cancer Mortality
9%
Community-Dwelling Older Adults
9%
All Cause Mortality
8%
Diseases
7%
Hypertension
6%
Postherpetic Neuralgia
6%
Cancer
6%
Decompensated Liver Cirrhosis
5%
Skin Defect
5%
COVID-19 Vaccination
5%
Pediatrics
5%
Socioeconomic Status
5%
Vitiligo
5%
Cardiovascular Disease
5%
Lung Cancer
5%
Body Mass Index
5%
Dermatitis
5%
Chronic Kidney Disease
5%
Nursing and Health Professions
Cohort Analysis
65%
Hazard Ratio
31%
Confidence Interval
31%
Body Mass
19%
Psoriasis
18%
Bullous Pemphigoid
18%
All Cause Mortality
16%
Atopic Dermatitis
13%
Cancer Mortality
11%
National Health Insurance
11%
Gerontology
11%
Diseases
11%
Cardiovascular Mortality
10%
Comorbidity
10%
Cigarette Filter
10%
Cardiovascular Disease
9%
Malignant Neoplasm
9%
Palliative Therapy
9%
Vitiligo
9%
Hepatitis B
9%
Odds Ratio
8%
Hypertension
8%
Alcohol Consumption
7%
Medical Examination
6%
Socioeconomic Status
6%
Ward
6%
Proportional Hazards Model
5%
Cardiovascular System
5%
Long Term Care
5%
Adherence
5%
Chronic Kidney Failure
5%
